XenoBiotic Laboratories' (XBL's) experienced staff and state-of-the-art instrumentation set the standard for analytical and bioanalytical services for NCE and generic development programs.
“When we searched for a contract research organization to supplement our in house efforts in drug metabolite profiling and identification our criteria included scientific excellence, responsiveness to timelines, and the ability to interact with our metabolism scientists one-on-one. XBL met these qualifications and has worked closely with us to form a successful partnership in this area.”
Lewis Klunk, Ph.D. Executive Director, Bioanalytical Sciences and Clinical Discovery Analytical Sciences, Bristol-Myers Squibb Company, Pharmaceutical Research Institute, Princeton, NJ, and Wallingford, CT